AR107093A1 - Composiciones inmunogénicas - Google Patents

Composiciones inmunogénicas

Info

Publication number
AR107093A1
AR107093A1 ARP160103905A ARP160103905A AR107093A1 AR 107093 A1 AR107093 A1 AR 107093A1 AR P160103905 A ARP160103905 A AR P160103905A AR P160103905 A ARP160103905 A AR P160103905A AR 107093 A1 AR107093 A1 AR 107093A1
Authority
AR
Argentina
Prior art keywords
immunogenic compositions
compositions
increasing
immune response
response against
Prior art date
Application number
ARP160103905A
Other languages
English (en)
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Publication of AR107093A1 publication Critical patent/AR107093A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16—HIV-1 ; HIV-2
    • C07K14/162—HIV-1 ; HIV-2 env, e.g. gp160, gp110/120, gp41, V3, peptid T, CD4-Binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Composiciones útiles para, por ejemplo, aumentar una respuesta inmunitaria contra el VIH-1, y procedimientos asociados de aumento de una respuesta inmunitaria contra el VIH en un sujeto mamífero. En algunos modos de realización, las composiciones son composiciones inmunógenas bivalentes que comprenden dos (o, en algunos modos de realización más de dos) antígenos polipéptido gp120 de la envuelta del virus de la inmunodeficiencia humana (VIH) de clado C, junto con un adyuvante basado en liposomas, tal como el adyuvante conocido como AS01.
ARP160103905A 2015-12-17 2016-12-16 Composiciones inmunogénicas AR107093A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562268715P 2015-12-17 2015-12-17

Publications (1)

Publication Number Publication Date
AR107093A1 true AR107093A1 (es) 2018-03-21

Family

ID=57838313

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160103905A AR107093A1 (es) 2015-12-17 2016-12-16 Composiciones inmunogénicas

Country Status (4)

Country Link
US (1) US20180360949A1 (es)
AR (1) AR107093A1 (es)
BE (1) BE1024161B1 (es)
WO (1) WO2017103236A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015095499A1 (en) * 2013-12-18 2015-06-25 Duke University Cap260, cap174 and k0224 hiv-1 envelopes, peptide and compositions

Also Published As

Publication number Publication date
US20180360949A1 (en) 2018-12-20
BE1024161B1 (fr) 2017-11-24
BE1024161A1 (fr) 2017-11-23
WO2017103236A1 (en) 2017-06-22

Similar Documents

Publication Publication Date Title
CY1124756T1 (el) Εξουδετερωτικα αντισωματα του ιου ανθρωπινης ανοσοανεπαρκειας
BR112018011122A2 (pt) antígenos, vetores, composições, e métodos de utilização para o vírus da imunodeficiência humana dos mesmos
MX2020013153A (es) Metodos y composiciones para inducir inmunidad protectora contra la infeccion por virus de inmunodeficiencia humana.
EA201591287A1 (ru) Вакцины, содержащие стабилизированные тримеры оболочки вируса иммунодефицита человека, и способы их применения
CL2017001920A1 (es) Anticuerpos humanos contra glicoproteína del virus ébola
UY33297A (es) Composiciones farmaceuticas que comprenden un polipéptido que comprende al menos un motivo cxxc y antígenos heterólogos y usos de las mismas
EA201892233A1 (ru) Композиции и способы, связанные с иммуногенами вич-1
EA201290956A1 (ru) Вакцина против вич
MX2020004543A (es) Vacunas contra el zika, composiciones inmunogenicas y metodos que las utilizan.
WO2017151801A8 (en) Compositions comprising hiv envelopes to induce ch235 lineage antibodies
EP3052518A4 (en) Stabilized human immunodeficiency virus (hiv) clade c envelope (env) trimer vaccines and methods of using same
DOP2023000137A (es) Vacunas contra el vih y métodos de uso
ECSP18081582A (es) Constructos de alfavirus vivo atenuado y métodos y usos de los mismos
AR114560A1 (es) Proteínas antigénicas de la envoltura del virus de inmunodeficiencia humano expresadas en mamíferos
EP3526236A4 (en) SIGNATURE-BASED HUMAN IMMUNODEFICIENCY VIRUS VACCINES (ENV) CONTAINING SIGNS AND METHODS OF USE THEREOF
AR107093A1 (es) Composiciones inmunogénicas
WO2015048796A3 (en) Mosaic hiv envelope immunogenic polypeptides
BR112021025286A2 (pt) Vacina contra o hiv com base em células t alogênicas para induzir a imunidade celular e humoral
ZA202104747B (en) Novel trypanosomal vaccine
ES2401904R1 (es) Vectores recombinantes basados en el virus modificado de ankara (mva), con delecion en el gen c6l, como vacunas contra el vih/sida y otras enfermedades.
ZA202104746B (en) Novel trypanosomal vaccine
AR117942A1 (es) Vacunas contra el zika, composiciones inmunogénicas y métodos que las utilizan
WO2020081895A3 (en) Siv envelope trimer
EA202191862A3 (ru) Антигены вируса иммунодефицита человека, векторы, композиции и способы их применения
AR105134A1 (es) Vacunas contra la influenza con coincidencia antigénica

Legal Events

Date Code Title Description
FB Suspension of granting procedure